BridgeMD
Compares treatment options for Coronary Artery Disease
Official title MiECC Versus Conventional Cardiopulmonary Bypass in Cardiac Surgery (MiECS)
ClinicalTrials.gov ID: NCT05487612
What this study is testing
- What it's testing
- MiECS is one of the largest multicentre randomised controlled trials on extracorporeal circulation conducted under the auspices of Minimal Invasive Extracorporeal Technologies International Society (MiECTiS). It is designed to ultimately address the emerging effectiveness of MiECC systems in the light of modern perfusion practice worldwide.
- Which group you join is decided by chance.
A plain-language read of the study's public ClinicalTrials.gov listing. The study team confirms the details.
Who can take part
Ages 18 to 85
You may be able to join if
- All patients undergoing any elective or urgent coronary artery bypass grafting (CABG), aortic valve replacement (AVR) or CABG+AVR surgery using...
You likely can't join if
- Requirement for emergency or salvage operation.
- Requirement for major aortic surgery (e.g. aortic root replacement).
- Contraindication or objection (e.g. Jehovah's Witnesses) to transfusion of blood products.
- Congenital or acquired platelet, red cell or clotting disorders (patients with iron deficient anaemia will not be excluded).
- Inability to give informed consent for the study (e.g. learning or language difficulties).
The study team makes the final eligibility decision.
Where it's taking place
- Toronto, Canada
- Coswig, Germany
- Göttingen, Germany
- Ulm, Germany
- Thessaloniki, Greece
- Bari, Italy
- Palermo, Italy
- Ankara, Turkey (Türkiye)
- Izmir, Turkey (Türkiye)
- Rize, Turkey (Türkiye)
- Cambridge, United Kingdom
- Hull, United Kingdom
- London, United Kingdom
Questions & answers
Do participants get paid in this trial?
This listing doesn't specify compensation. Many trials still reimburse travel or offer a stipend, so it's worth asking the study team when you connect.
Is it free to join, and do I need insurance?
Searching and applying through BridgeMD is free. In clinical trials the study-related treatment and visits are generally provided at no cost to you. You usually don't need insurance to take part - confirm specifics with the study team.
How long does this study last?
The listing doesn't state an exact length. The study team walks you through the schedule and number of visits before you decide to enroll.
Who can join this trial?
This study is enrolling all sexes, 18 years to 85 years. The study team makes the final eligibility decision.
Where is this trial taking place?
Study sites include Toronto, Canada; Coswig, Germany; Göttingen, Germany; Ulm, Germany; Thessaloniki, Greece; Bari, Italy and 7 more location(s). Enter your location above to see the nearest site and check your eligibility.
Explore other conditions
BridgeMD is an information and trial-matching tool - not medical advice, and not the study sponsor. Details come from ClinicalTrials.gov; the study team decides eligibility.